LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
Podcasts & Webcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
BioCentury-BayHelix China Healthcare Summit
East-West Healthcare Reception
BioCentury-BayHelix East-West Summit
Bio€quity Europe
BioCentury Grand Rounds Inquiry
Grand Rounds U.S.
Grand Rounds Europe
The BioCentury Show
Webinars - Upcoming & On-Demand
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Jan 13, 2025
Deals
Lilly catches Relay in PI3Ka race via Scorpion acquisition
A spinout will house precision oncology assets from Scorpion
Read More
BioCentury
|
Dec 12, 2024
Data Byte
Candel leads biotech gainers amid wave of data readouts
Prostate cancer data lead to a nearly 70% stock bump; dermatitis data sink Q32 shares
Read More
BioCentury
|
Nov 9, 2024
Data Byte
FDA’s October approvals include the first CLDN18.2 mAb
Plus: Agency approves Pfizer’s hemophilia A and B mAb, and label expansions for five products
Read More
BioCentury
|
Oct 24, 2024
Product Development
Vaderis: A case study in navigating the orphan drug development maze
Company went from idea to clinical proof of concept for
Read More
BioCentury
|
Sep 13, 2024
Finance
Public Equity Report: Biotech quintet raises $1.3B+ via follow-ons
Ionis tops list of five biotechs raising at least $200M in public offerings, along with Centessa, Viridian, Relay and Xencor; plus PIPEs keep flowing
Read More
BioCentury
|
Sep 12, 2024
Product Development
Clinical Report: AstraZeneca, Daiichi turn to precision medicine after OS miss for Dato-DXd
Plus: Results from Relay, Centessa, Viridian, Amgen and more
Read More
BioCentury
|
Jul 18, 2024
Finance
Venture Report: Five biotechs raise nearly $800M in two-day flurry
Plus: New capital for CytoReason, Truvian and Renalys
Read More
BioCentury
|
Jun 21, 2024
Finance
Venture Report: Syncona’s backs a pair of biotechs; Marea makes debut with $190M
Plus: Forbion’s new sustainability fund, and rounds for Elion, ashibio, NephroDI and Ability
Read More
BioCentury
|
May 31, 2024
Finance
Public Equity Report: Insmed, Merus raise combined $1B+ after readouts
Plus: PIPEs help Celcuity, Cargo advance clinical programs
Read More
BioCentury
|
May 17, 2024
Finance
Public Equity Report: Erasca reboots, Telix plans NASDAQ listing
Plus: OnKure goes public via reverse merger, Monte Rosa and Allogene each raise $100M+, and Incyte’s $2B buyback
Read More
Items per page:
10
1 - 10 of 870